David Schneider
Allergy & Immunology · Metairie, LANPI 1275590945
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.9% of the total across 438 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 13.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $2,676 and has fallen 91.2% since, to $235 in 2025.
Across 438 payments — averaging $22.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- Genentech USA, Inc.$983
- GSK$934
- Regeneron Healthcare Solutions, Inc.$751
- Sanofi$707
- Pfizer$673
- plus $4K from 28 others
Across 23 payments — averaging $3536.33 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sanofi US Services Inc.$55K
- Sanofi$26K
What the payments were for
- Food & beverage$9,802100%
- Education$60%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 57 | $1,341 |
| Genentech USA, Inc. | 21 | $983 |
| GSK | 48 | $934 |
| Regeneron Healthcare Solutions, Inc. | 39 | $751 |
| Sanofi | 24 | $707 |
| Pfizer | 30 | $673 |
| Amgen | 10 | $588 |
| Takeda Pharmaceuticals U.S.A., Inc. | 23 | $540 |
| Teva Pharmaceuticals USA, Inc. | 46 | $487 |
| AbbVie(2 entities) | 29 | $476 |
| Grifols USA, LLC | 19 | $389 |
| CSL Behring | 16 | $323 |
| Optinose US, Inc. | 9 | $175 |
| Incyte Corporation | 2 | $153 |
| Kaleo, Inc. | 9 | $152 |
| Bio Products Laboratory USA, Inc. | 6 | $147 |
| Novartis | 6 | $136 |
| Alk-abello, Inc | 7 | $110 |
| Biocryst US Sales Co., LLC | 6 | $109 |
| Aimmune Therapeutics, Inc. | 4 | $92 |
| Boehringer Ingelheim | 5 | $79 |
| Shire North American Group Inc | 4 | $71 |
| Pharming Healthcare, Inc. | 3 | $58 |
| ADMA Biomanufacturing LLC | 3 | $55 |
| Octapharma USA, Inc. | 1 | $47 |
| Ortho Organizers, Inc. | 1 | $42 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $42 |
| Biocryst Pharmaceuticals, Inc. | 2 | $33 |
| Biohaven Pharmaceuticals, Inc. | 1 | $27 |
| LEO Pharma Inc. | 1 | $23 |
| USWM, LLC | 1 | $19 |
| Sanofi-aventis U.S. LLC | 1 | $19 |
| Eyevance Pharmaceuticals LLC | 1 | $16 |
| Greer Laboratories, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,808 in reported general payments places this provider in the 80th percentile of 62 allergy & immunology providers in Louisiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gammagard LiquidImmun Glob G(Igg)/Gly/Iga Ov50 | 11 | $72,522 |
| Dupixent SyringeDupilumab | 13 | $49,699 |
| Montelukast Sodium | 14 | $70 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc.Gammagard Liquid | $540 | $72,52211 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 62 allergy & immunology providers in Louisiana.
Other allergy & immunology in Metairie
- Sarah QayumMetairie$11K
- Jeffery FranklinMetairie$9K
- Sweta ShahMetairie$7K
- Alice HoytMetairie$7K
- Tammy HarveyMetairie$7K
- Alan SheenMetairie$4K
- David KaufmanShreveport$678K
- Reena MehtaNew Orleans$159K
- Kenneth ParisNew Orleans$150K
- Brice RolstonCovington$54K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.